BRR : 3351786
Tender Brief : Supply Of 187 Anti Cancer (Generic / Innovator On Demand) Drugs In Rcc On Rate Contract Basis Supply 187 Anti Cancer (Generic / Innovator On Demand) Drugs In Regional Cancer Centre, Trivandrum On Rate Contract Basis , Abiraterone Tab Ip ,250 Mg , Actinomycin D Inj ,0.5Mg/3Ml , Amifostine For Inj Usp ,500Mg , Anastrazole Tab Ip ,1Mg , Arsenic Trioxide Inj ,10 Mg , Azacitidine Inj ,100 Mg , Bendamustine Inj Ip ,100Mg , Bevacizumab Inj. ,100Mg , Bicalutamide Tab Ip ,50Mg , Bleomycin Inj Ip ,15 Units , Bortezomib Inj Ip ,2Mg , Busulphan Inj ,60 Mg , Cabazitaxel Inj ,60 Mg , Calcium Leucovorin Tab... Read More
Tender Value
₹
Ref. Document
Contract Value
₹ 38,53,75,722.8
Submission Date
02-02-2024
Contract Date
28-06-2024
Completion Date
45 days
Participated Bidder List
39 No of Bidder(s)
| Sr No. | Bidder Name | Bid Analytics | Technical Bid | Financial Bid | AOC | Bid Value | Rank |
|---|---|---|---|---|---|---|---|
| 1 | cnet-technologies | Bid Analytics | 3,51,60,710 | L1 | |||
| 2 | cnet-technologies | Bid Analytics | |||||
| 3 | cnet-technologies | Bid Analytics | 1,74,79,419.4 | L1 | |||
| 4 | cnet-technologies | Bid Analytics | 1,32,98,482.5 | L1 | |||
| 5 | cnet-technologies | Bid Analytics | 80,32,895 | L1 | |||
| 6 | cnet-technologies | Bid Analytics | L1 | ||||
| 7 | cnet-technologies | Bid Analytics | 14,78,400 | L1 | |||
| 8 | cnet-technologies | Bid Analytics | 1,43,79,750 | L1 | |||
| 9 | cnet-technologies | Bid Analytics | 90,60,065 | L1 | |||
| 10 | cnet-technologies | Bid Analytics | L1 | ||||
| 11 | cnet-technologies | Bid Analytics | 3,11,30,755.6 | L1 | |||
| 12 | cnet-technologies | Bid Analytics | 31,18,650 | L1 | |||
| 13 | cnet-technologies | Bid Analytics | 9,96,800 | L1 | |||
| 14 | cnet-technologies | Bid Analytics | L1 | ||||
| 15 | cnet-technologies | Bid Analytics | 30,75,000 | L1 | |||
| 16 | cnet-technologies | Bid Analytics | L1 | ||||
| 17 | cnet-technologies | Bid Analytics | 18,14,920 | L1 | |||
| 18 | cnet-technologies | Bid Analytics | 89,95,234 | L1 | |||
| 19 | cnet-technologies | Bid Analytics | |||||
| 20 | cnet-technologies | Bid Analytics | 27,00,600 | L1 | |||
| 21 | cnet-technologies | Bid Analytics | |||||
| 22 | cnet-technologies | Bid Analytics | 1,71,52,872 | L1 | |||
| 23 | cnet-technologies | Bid Analytics | 81,32,346 | L1 | |||
| 24 | cnet-technologies | Bid Analytics | 4,35,285 | L1 | |||
| 25 | cnet-technologies | Bid Analytics | 2,12,49,996 | L1 | |||
| 26 | cnet-technologies | Bid Analytics | 1,59,34,240 | L1 | |||
| 27 | cnet-technologies | Bid Analytics | 1,65,37,500 | L1 | |||
| 28 | cnet-technologies | Bid Analytics | 29,31,172.8 | L1 | |||
| 29 | cnet-technologies | Bid Analytics | 1,08,27,295 | L1 | |||
| 30 | cnet-technologies | Bid Analytics | L1 | ||||
| 31 | cnet-technologies | Bid Analytics | 1,10,25,980 | L1 | |||
| 32 | cnet-technologies | Bid Analytics | 6,13,05,550 | L1 | |||
| 33 | cnet-technologies | Bid Analytics | 3,44,20,960 | L1 | |||
| 34 | cnet-technologies | Bid Analytics | 44,18,265 | L1 | |||
| 35 | cnet-technologies | Bid Analytics | 60,74,880 | L1 | |||
| 36 | cnet-technologies | Bid Analytics | 1,49,85,600 | L1 | |||
| 37 | cnet-technologies | Bid Analytics | 5,73,971.5 | L1 | |||
| 38 | cnet-technologies | Bid Analytics | 48,07,987 | L1 | |||
| 39 | cnet-technologies | Bid Analytics | 38,40,141 | L1 |
Work Detail
supply of 187 anti cancer (generic / innovator on demand) drugs in rcc on rate contract basis supply 187 anti cancer (generic / innovator on demand) drugs in regional cancer centre, trivandrum on rate contract basis , abiraterone tab ip ,250 mg , actinomycin d inj ,0.5mg/3ml , amifostine for inj usp ,500mg , anastrazole tab ip ,1mg , arsenic trioxide inj ,10 mg , azacitidine inj ,100 mg , bendamustine inj ip ,100mg , bevacizumab inj. ,100mg , bicalutamide tab ip ,50mg , bleomycin inj ip ,15 units , bortezomib inj ip ,2mg , busulphan inj ,60 mg , cabazitaxel inj ,60 mg , calcium leucovorin tab ,15 mg , capecitabine tab ip ,500mg , carfilzomib inj. ,60mg , carmustine inj ip/usp ,100 mg , ceritinib cap ,150 mg , chlorambucil tab ip ,2mg , crizotinib cap ,250 mg , cyclophosphamide tab ip ,50mg , dacarbazine inj ip/usp ,200mg , daunorubicin inj ip ,20mg , decitabine inj ,50 mg , denosumab inj 120mg , doxorubicin liposomal inj ,20mg , enzalutamide cap ,40 mg , eribulin inj ,0.88 mg/ml , erlotinib tab ip ,100mg , erlotinib tab ip ,150mg , etoposide cap ip ,50mg , etoposide inj ip ,100mg , everolimus tab ,5mg , exemestane tab ,25mg , filgrastim inj ,300 mcg (pfs) , filgrastim inj ,300 mcg (vial) , fludarabine phosphate inj ip / usp, 50mg , fludarabine tab ,10 mg , fulvestrant inj ,250mg , gefitinib tab ip ,250mg , hydroxy urea cap ip ,500mg , ibandronate tab ,150mg , ibandronate tab ,50mg , ibrutinib cap 140mg , lapatinib tab ip ,250mg , lenalidomide cap ,10mg , letrozole tab ip/usp ,2.5mg , lomustine cap ip ,40mg , megestrol acetate tab ip ,40 mg , melphalan inj ip, 50mg , melphalan tab ,5mg , mercaptopurine tab ip ,10 mg , mercaptopurine tab ip ,50 mg , mesna inj ,200mg , methotrexate inj (intrathecal, preservative free) ,15mg , methotrexate inj ip ,50mg , methotrexate tab ip ,2.5mg , mitomycin inj ip ,10mg , mitozantrone infusion bp/usp ,20mg , nilotinib cap ,200 mg , octreotide depot inj ,20mg , octreotide depot inj ,30mg , octreotide inj ,100 mcg/ml , olaparib tab ,150 mg , osimertinib tab ,80 mg , pazopanib tab ,400 mg , pegfilgrastim inj ,6mg , peg-l-asparaginase inj 750 iu/ml , procarbazine hcl cap ip ,50mg , protein bound paclitaxel inj ,100mg , rasburicase inj 1.5mg , regorafenib tab 40mg , sorafenib tosylate tab ip ,200mg , tamoxifen tab ip ,20mg , tegafur +uracil cap ,100mg + 224mg , thalidomide cap 100mg , topotecan inj ip ,2.5mg , trabectedin inj ,1 mg , tretinoin cap ,10 mg , vinblastine sulphate inj ip ,10mg , vincristine sulphate inj ip/usp ,1mg , vinorelbine inj ip ,50mg , zoledronic acid inj ip ,4mg , 13-cis-retinoic acid cap ,10 mg , 13-cis-retinoic acid cap ,20 mg , 13-cis-retinoic acid cap ,40 mg , afatinib tab ,30 mg , afatinib tab ,40 mg , calcium leucovorin inj ip ,15mg , calcium leucovorin inj ip ,50mg , carboplatin inj ip ,150mg , carboplatin inj ip ,450mg , cisplatin inj ip ,10mg , cisplatin inj ip ,50mg , cyclophosphamide inj ip ,200mg , cyclophosphamide inj ip ,500mg , cytarabine inj ip/bp ,1 gm , cytarabine inj ip/bp ,100mg , dasatinib tab ,20mg , dasatinib tab ,50mg , docetaxel inj ip ,120mg , docetaxel inj ip ,20mg , docetaxel inj ip ,80mg , doxorubicin inj (lyophilised) ip ,10mg , doxorubicin inj (lyophilised) ip ,50mg , epirubicin inj bp/usp ,10mg , epirubicin inj bp/usp ,50mg , flurouracil inj ip ,250mg , flurouracil inj ip ,500mg , gemcitabine inj ip ,200mg , gemcitabine inj ip. ,1gm , ifosfamide with mesna inj ,1gm , ifosfamide with mesna inj ,2gm , imatinib tab ip ,100mg , imatinib tab ip ,400 mg , irinotecan inj ip ,100mg , irinotecan inj ip ,40mg , l.asparaginase inj ,10000 iu , l.asparaginase inj ,5000 iu , leuprolide acetate inj ,11.25mg , leuprolide acetate inj ,22.5mg , leuprolide acetate inj ,3.75mg , methotrexate inj ip ,1 gm , methotrexate inj ip ,500 mg , oxaliplatin inj ip ,100mg , oxaliplatin inj ip ,50mg , paclitaxel inj ip ,30mg , paclitaxel inj ip with codon set ,100mg , paclitaxel inj ip with codon set ,260mg , pemetrexed inj ip ,100mg , pemetrexed inj ip. ,500mg , pomalidomide cap ,2 mg , pomalidomide cap ,4 mg , rituximab inj ,500mg , rituximab inj. ,100mg , sunitinib cap, 25 mg , sunitinib cap, 50 mg , temozolomide cap ip ,100mg , temozolomide cap ip ,20mg , temozolomide cap ip ,250mg , trastuzumab emtansine 100mg , trastuzumab emtansine 160mg , trastuzumab inj ,150 mg , trastuzumab inj. ,440mg , degarelix inj ,120 mg , degarelix inj ,80 mg , lenvatinib cap, 10 mg , lenvatinib cap, 4 mg , palbociclib tab 100 mg , palbociclib tab 125 mg , palbociclib tab 75 mg , abemaciclib tab 150 mg , alectinib tab ,150 mg , alpelisib tab 150 mg , atezolizumab inj ,1200 mg/ 20ml , axitinib tab ,5 mg , bevacizumab inj ,100mg , capecitabine tab ip ,500mg , cetuximab inj ,100mg , cladribine inj ,10mg , cytarabine inj ip/bp ,1 gm , cytarabine inj ip/bp ,100mg , daratumumab inj ,100mg/5ml , daratumumab inj ,400mg/20ml , daunorubicin inj ip ,20mg , denosumab inj 120mg , doxorubicin inj (lyophilised) ip ,10mg , doxorubicin inj (lyophilised) ip ,50mg , goserelin 10.8 mg inj , idarubicin inj ,5 mg , nimotuzumab inj ,200 mg , nivolumab inj ,10 mg/ml , nivolumab inj ,40 mg , olaparib tab ,150 mg , osimertinib tab ,80 mg , palbociclib tab ,100 mg , palbociclib tab ,125 mg , panitumumab inj ,100 mg , pembrolizumab inj ,100mg , pertuzumab inj ,420 mg , ramucirumab inj 500mg/5 ml , ribociclib tab ,200 mg , rituximab inj ,100mg , rituximab inj ,500mg , trastuzumab emtansine inj ,100 mg , trastuzumab emtansine inj ,160 mg , trastuzumab inj ,440mg
View Original Notice/Document
Result Documents
Tender Documents
Disclaimer
We takes all possible care for accurate & authentic tender information. However users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender
✦ ✦ ✦
Awarded Bidder(s)
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
Similar Tenders Results